Categories:

Cannabinoids in pharmaceutical development

The development of cannabinoids in the pharmaceutical industry has exploded over the past few years. With the gradual liberation of regulations worldwide that govern cannabis and its pharmaceutical derivatives for medicinal use, this week…

Top 10 Pharma Trends 2020

What key trends or issues emerged in 2019 that are positioned to be on the industry’s radar in 2020? DCAT Value Chain Insights provides a Top 10 ranking. Article by By Patricia Van Arnum - DCAT Editorial Director 1. Drug-pricing reform…

The Pharmaceutical Industry Year 2019 in Review

As 2019 comes to a close, what was the top news stories shaping the pharmaceutical industry? From mega acquisitions to deal-making in cell and gene therapies, to shifting supply lines from a still-to-be resolved Brexit and ongoing trade…

Orodispersible Mini-tablets based on galenIQ™ 721

Orodispersible mini-tablets (ODMTs) are becoming increasingly more important to pharmaceutical companies, as the clinical benefit for peadiatric patients has been proven. In literature mini-tablets are described as solid dosage forms with a…

Poster presentation Gattefossé

See the presentation of Sophie Hughes from Gattefossé at CPhI Worldwide where she talked through a poster presentation on the formulating of cannabinoids with lipid excipients. To find out more about this and Gattefossé´s whole portfolio of…